Ronald Asbury Andrews - Jul 1, 2021 Form 4 Insider Report for OncoCyte Corp (OCX)

Role
Chief Executive Officer, Director
Signature
/s/ Ronald Andrews
Stock symbol
OCX
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 09:32 PM
Previous filing
Jul 2, 2021
Next filing
Aug 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Options Exercise $0 +65K +33.5% $0.00 259K Jul 1, 2021 Direct
transaction OCX Common Stock, no par value Tax liability $0 -15.8K -6.11% $0.00 243K Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Restricted Stock Units Options Exercise $0 -65K -100% $0.00* 0 Jul 1, 2021 Common Shares 65K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 65,000 Restricted Stock Units.
F2 Restricted Stock Units vested on July 1, 2021.